BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients’ ...

A downtrend has been apparent in Aileron Therapeutics, Inc. (ALRN) lately. While the stock has lost 14.6% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in ...